GYG PLC Trading above expectations

Remy Millott, CEO of GYG commented:

“I am pleased that the momentum we experienced in Q1 continued through Q2 and that the Group performed well across all business units. We are looking forward to a busy Monaco Yacht Show in September and continued market performance through the remainder of 2019.

“I would like to take this opportunity, on behalf of the Board, to thank Gloria for her valuable contribution over the last seven years and we wish her the best of luck on the next stage of her journey.”

GYG PLC (LON:GYG), the market leading superyacht painting, supply and maintenance company, today provided the following trading update for the six months ended 30 June 2019.

The Group is pleased to announce that the positive momentum that was reported on 21 May 2019 has continued through Q2 and, as a result, the Board expects that profit performance for the full financial year will be ahead of current market expectations. This performance has been driven by continued improvement across the business.

CFO Change

The Board also announces that, after seven years with the Group and successfully leading the finance function through the IPO in 2017, Gloria Fernandez has informed the Board of her intention not to return to the Group after her maternity leave. The Group’s Interim CFO, Kevin McNair, who has been in place during Gloria´s maternity leave will continue in the role for the foreseeable future.

The Group will report its Interim Results for the six months ended 30 June 2019 on 26 September 2019.

Click to view all articles for the EPIC: ,
Or click to view the full company profile:
Facebook
Twitter
LinkedIn
GYG Plc

More articles like this

Guild Esports sign two-year gaming chair sponsorship with Razer

Guild Esports plc (LON:GILD; OTCQB: GULDF), a global teams organisation and lifestyle brand, has welcome Razer as the Company’s Official Gaming Chair Partner with the signing of a two-year global sponsorship deal. The total contract value, which

Redde Northgate trading ahead of expectations

Redde Northgate plc (LON:REDD), the leading integrated mobility solutions platform providing services across the vehicle lifecycle, has announced a trading update for the year ended 30 April 2022, ahead of its results for the year scheduled

Inchcape

Inchcape update on Russian operations

Inchcape plc (LON:INCH) is deeply saddened by the ongoing conflict in Ukraine and the enormous humanitarian impact on all those affected. We share the hopes of the world for a peaceful resolution. In light of the current

STRIX GROUP PLC ORD 1P

Strix Group to conduct investor presentation on 31st March 2022

Strix Group plc (LON:KETL), the global leader in the design, manufacture and supply of kettle safety controls and other complementary water temperature management components will be conducting an investor presentation covering their Full Year results to the period

City of London Investment Group plc

City of London Investment Group Barry Olliff increases holding

City of London Investment Group plc (LON:CLIG), a leading specialist asset management group offering a range of institutional and retail products investing primarily in closed-end funds, stated that it has been notified that Stable View III LP,

CentralNic

CentralNic Group continue to beat expectations (Analyst Interview)

CentralNic Group Plc (LON:CNIC) is the topic of conversation when Bob Liao Director and Research Analyst at Zeus Capital joins DirectorsTalk Interviews. Bob provides us with an overview of VGL, explains how the acquisition fits in with CentalNic’s business,

Guild Esports wins fifth major trophy

Guild Esports plc (LON:GILD; OTCQB: GULDF), a global team organisation and lifestyle brand, has announced that it has won its fifth major trophy after its Fortnite pro-player, Henrik Mclean (‘Hen’), achieved first place in the prestigious Fortnite

Oncimmune signs new commercial follow-on contract 

Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, has announced the signing of a new commercial follow-on contract with a world-leading medical research organisation based in the US, to validate the findings from a previous